Gene · 3490
Papers3,920
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,920
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Proteomic Profile of Adults With a Fontan Circulation. | JACC Adv | 2026 | 42312768 | PubTator, text mining | PubMed |
| Hydrating with a higher-fructose sport drink does not worsen acute kidney injury risk during simulated work-related heat stress. | Am J Physiol Regul Integr Comp Physiol | 2026 | 42302737 | PubTator, text mining | PubMed |
| Water intake mediates cross-sectional associations between urinary kidney injury biomarkers and race in emerging adults. | Am J Physiol Regul Integr Comp Physiol | 2026 | 42267936 | PubTator, text mining | PubMed |
| Plasma exosomal microRNAs as early predictors of subclinical acute kidney injury in septic patients undergoing major non-cardiac surgery: a prospective observational cohort study. | Sci Rep | 2026 | 42251093 | PubTator, text mining | PubMed |
| An integrated single-cell and spatial proteotranscriptomics atlas of fibroblast-driven immunoregulation within the human adult oral cavity. | Cell Press Blue | 2026 | 42147490 | PubTator, text mining | PubMed |
| IGFBP7 in multiple sclerosis: A marker of compartmentalized inflammation with limited diagnostic specificity. | Mult Scler Relat Disord | 2026 | 42142450 | PubTator, text mining | PubMed |
| Comprehensive assessment of novel cardiovascular biomarkers in AF. | Europace | 2026 | 42138155 | PubTator, text mining | PubMed |
| Biomarker-Based Diagnosis and Risk Stratification in Sepsis-Associated Acute Kidney Injury: From Molecular Mechanisms to Multimarker Panels. | Diagnostics (Basel) | 2026 | 42121966 | PubTator, text mining | PubMed |
| Decreased serum IGFBP-7 level is associated with cognitive impairment in first-episode drug-naïve adolescent-onset schizophrenia. | Ann Gen Psychiatry | 2026 | 42121223 | PubTator, text mining | PubMed |
| Circulating levels of insulin-like growth factor binding protein 7 are associated with risks of chronic diseases and death. | NPJ Aging | 2026 | 42103769 | PubTator, text mining | PubMed |
| Research progress on biomarkers for acute kidney injury in children. | Pediatr Nephrol | 2026 | 42086806 | PubTator, text mining | PubMed |
| Novel biomarkers in acute kidney injury: their role in the diagnosis of kidney dysfunction and etiology definition, their potential as predictive markers of structural renal damage severity. | Intern Emerg Med | 2026 | 42081082 | PubTator, text mining | PubMed |
| A novel risk stratification strategy for precision prevention of gastric cancer based on clinicopathological features and IGFBP7. | Sci Rep | 2026 | 42032043 | PubTator, text mining | PubMed |
| Cast nephropathy in the ICU: Early recognition and extracorporeal strategies to improve outcomes. | J Intensive Med | 2026 | 42028141 | PubTator, text mining | PubMed |
| Exploring the regulatory mechanisms of antidiabetic drugs on osteoporosis and Bone mineral density. | Exp Gerontol | 2026 | 42025820 | PubTator, text mining | PubMed |
| Cross-Cohort Evidence of Editome Dysregulation and Cell Growth-Related IGFBP7 Recoding Driven by ADARB1 in Fuchs Endothelial Corneal Dystrophy. | Invest Ophthalmol Vis Sci | 2026 | 42017307 | PubTator, text mining | PubMed |
| IGFBP7 and Heart Failure: From Senescence Biomarker to Therapeutic Target. | Curr Heart Fail Rep | 2026 | 42012548 | PubTator, text mining | PubMed |
| Chrysin attenuates tramadol-driven renal dysfunction via regulation of RNA networks, antioxidant pathways, and ketogenic metabolism. | Eur J Pharmacol | 2026 | 42002091 | PubTator, text mining | PubMed |
| Dual biomarker strategy with [TIMP-2]·[IGFBP7] and copeptin enhances early diagnosis and risk prediction in HRS-AKI. | Nefrologia (Engl Ed) | 2026 | 41997689 | PubTator, text mining | PubMed |
| Dissecting molecular heterogeneity in primary gastric cancer by IGFBP7-related analysis. | J Transl Med | 2026 | 41981670 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3490/papers?page=3